Search research articles
Contact Us
Filters
Showing results (551-560 of 594) with videos related to
Page
of 60
Sort By:
Biological Psychiatry
|
May 3, 2011
Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders
Cameron S Carter, Deanna M Barch, Edward Bullmore, et al.
The Journal of Clinical Psychiatry
|
December 7, 2007
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update
Troy A Moore, Robert W Buchanan, Peter F Buckley, et al.
The American Journal of Psychiatry
|
April 3, 2008
Initial phase 2 trial of a nicotinic agonist in schizophrenia
Robert Freedman, Ann Olincy, Robert W Buchanan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 3, 2009
Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia
Christine E Marx, Richard S E Keefe, Robert W Buchanan, et al.
Journal of Psychiatric Research
|
March 25, 2014
The effect of artemether on psychotic symptoms and cognitive impairment in first-episode, antipsychotic drug-naive persons with schizophrenia seropositive to Toxoplasma gondii
Hui-Ling Wang, Yu-Tao Xiang, Qiu-Ying Li, et al.
Molecular Autism
|
September 9, 2024
Task-based functional neural correlates of social cognition across autism and schizophrenia spectrum disorders
Lindsay D Oliver, Iska Moxon-Emre, Colin Hawco, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 18, 2013
Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia
L Fredrik Jarskog, Zhengchao Dong, Alayar Kangarlu, et al.
Schizophrenia Research
|
December 16, 2011
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia
Daniel C Javitt, Robert W Buchanan, Richard S E Keefe, et al.
The Journal of Clinical Psychiatry
|
May 4, 2004
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update
Alexander L Miller, Catherine S Hall, Robert W Buchanan, et al.
Archives of General Psychiatry
|
August 9, 2006
Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia
Hugh M D Gurling, Hugo Critchley, Susmita R Datta, et al.
Page
of 60
Search research articles
Search
Showing results (551-560 of 594) with videos related to
Sort By:
Page
of 60
Biological Psychiatry
|
May 3, 2011
Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders
Cameron S Carter, Deanna M Barch, Edward Bullmore, et al.
The Journal of Clinical Psychiatry
|
December 7, 2007
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update
Troy A Moore, Robert W Buchanan, Peter F Buckley, et al.
The American Journal of Psychiatry
|
April 3, 2008
Initial phase 2 trial of a nicotinic agonist in schizophrenia
Robert Freedman, Ann Olincy, Robert W Buchanan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 3, 2009
Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia
Christine E Marx, Richard S E Keefe, Robert W Buchanan, et al.
Journal of Psychiatric Research
|
March 25, 2014
The effect of artemether on psychotic symptoms and cognitive impairment in first-episode, antipsychotic drug-naive persons with schizophrenia seropositive to Toxoplasma gondii
Hui-Ling Wang, Yu-Tao Xiang, Qiu-Ying Li, et al.
Molecular Autism
|
September 9, 2024
Task-based functional neural correlates of social cognition across autism and schizophrenia spectrum disorders
Lindsay D Oliver, Iska Moxon-Emre, Colin Hawco, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 18, 2013
Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia
L Fredrik Jarskog, Zhengchao Dong, Alayar Kangarlu, et al.
Schizophrenia Research
|
December 16, 2011
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia
Daniel C Javitt, Robert W Buchanan, Richard S E Keefe, et al.
The Journal of Clinical Psychiatry
|
May 4, 2004
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update
Alexander L Miller, Catherine S Hall, Robert W Buchanan, et al.
Archives of General Psychiatry
|
August 9, 2006
Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia
Hugh M D Gurling, Hugo Critchley, Susmita R Datta, et al.
Page
of 60